Sterling Manor Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,770
Closed -$350K 80
2022
Q1
$350K Hold
6,770
0.28% 50
2021
Q4
$400K Buy
6,770
+500
+8% +$24.8K 0.31% 48
2021
Q3
$270K Buy
+6,270
New +$278K 0.23% 60

Other funds holding PFE

Sterling Manor Financial's PFE Position: Q2 2022 in Review

Sterling Manor Financial sold out of Pfizer (PFE) in Q2 2022, closing a stake of 6,770 shares — an estimated $350K sold.

Sterling Manor Financial first reported a position in PFE in Q3 2021 and held it in 3 quarters. The position peaked at $400K in Q4 2021. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • Sterling Manor Financial reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
  • Sterling Manor Financial sold 6,770 Pfizer shares in Q2 2022, an estimated $350K.
  • Sterling Manor Financial first reported a position in Pfizer in Q3 2021 and held it in 3 quarters.
  • Sterling Manor Financial's Pfizer position peaked at $400K in Q4 2021.
  • 3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Sterling Manor Financial's 13F filing for Q2 2022, filed 3 Aug 2022.